Health Canada has granted approval for GlaxoSmithKline’s ( GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...

The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

Indian Pharmaceuticals Market continued to report mid-single digit growth on year on year basis in October. IPM sales grew by ...

having served as head of international and commercial roles at Mirati Therapeutics (acquired by Bristol-Myers Squibb), Agios Pharmaceuticals (oncology business acquired by Servier) and at TESARO ...

The Pakistani Rupee has slipped against the US Dollar, with the exchange rate showing a slight decline in intra-day trading. The USD is trading at Rs277.80 in in the interbank market during intra-day ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 billion in 2024 and is expected to exhibit a CAGR of 7.6% by 2031 BURLINGAME, CA, UNITED STATES, November 12, 2024 ...